- Asked by: Jackie Baillie, MSP for Dumbarton, Scottish Labour
-
Date lodged: Friday, 17 January 2025
-
Current Status:
Answered by Jenni Minto on 24 January 2025
To ask the Scottish Government, in light of the commitment in its Stroke Improvement Plan 2023 to deliver a detailed plan for further development of the national thrombectomy service before the end of 2023, whether it remains committed to publishing such a plan, and, if so, when it plans to do so, and whether it will commit to publishing this in 2025.
Answer
The commitment in the Stroke Improvement Plan to publish a plan for further development of the national thrombectomy service in the second half of 2023 was published in December 2023, available at: Thrombectomy Service Update and Expansion Outline
It should be noted that, since publication, the National Thrombectomy Programme Board has, on the advice of NHS National Services Division, moved away from an options appraisal approach in favour of maximising access to thrombectomy and a stepwise approach to service expansion.
- Asked by: Jackie Baillie, MSP for Dumbarton, Scottish Labour
-
Date lodged: Thursday, 16 January 2025
-
Current Status:
Answered by Jenni Minto on 24 January 2025
To ask the Scottish Government whether it plans to have a national AI system in place to support delivery of mechanical thrombectomy, and, if so, when.
Answer
To date, significant work has been undertaken to develop robust criteria for a national AI solution to assist with identifying patients who may benefit from a thrombectomy.
A tendering process has commenced and the suitability and affordability of AI solutions will determine whether Scottish Government proceeds with procurement.
- Asked by: Jackie Baillie, MSP for Dumbarton, Scottish Labour
-
Date lodged: Wednesday, 15 January 2025
-
Current Status:
Answered by Jenni Minto on 24 January 2025
To ask the Scottish Government how much it has invested in clinical research into (a) dementia, (b) neurodegenerative conditions, (c) non-neurodegenerative conditions and (d) other neurological conditions in each of the last five years.
Answer
Within the Scottish Government, funding for Health and Care Research comes under the policy remit of the Chief Scientist Office (CSO)
CSO directly funds research through its research project and fellowship schemes. These are open to applications from across the clinical spectrum. All applications go through the same independent expert review process to enable funding decisions to be made
For multi-year projects and fellowships, the funding figure is allocated to the year corresponding to the start date and is the total amount committed to the project or fellowship
The 4 categories listed have been interpreted as follows:
Dementia - category including Alzheimer's; Frontotemporal Lobe Dementia; Lewy Body Dementia
2024-25 | 28,115 |
2023-24 | 299,999 |
2022-23 | 592,437 |
2021-22 | 260,978 |
2020-21 | 20,000 |
Neurodegenerative Conditions - category including MND/ALS; Multiple Sclerosis, Parkinson's
2024-25 | 132,368 |
2023-24 | 356,955 |
2022-23 | |
2021-22 | 1,947,038 |
2020-21 | 73,325 |
Non-neurodegenerative conditions - category including Epilepsy; Migraine; Seizures
2024-25 | |
2023-24 | 501,704 |
2022-23 | |
2021-22 | 379,814 |
2020-21 | |
Other neurological conditions - category including Ischaemic and Haemorrhagic Stroke; Cerebral Small Vessel Disease; Acquired Brain Injury
2024-25 | 550,919 |
2023-24 | 300,000 |
2022-23 | 856,698 |
2021-22 | 762,439 |
2020-21 | 78,744 |
In addition to directly funding research projects and fellowships, CSO also funds the NHS Research Scotland infrastructure that supports the running of Clinical Trials in the NHS here. This infrastructure includes topic-specific research networks which act as the interface between the research community, the NHS and patients themselves, facilitating the set up, delivery and completion of clinical studies across Scotland within their specific clinical areas
The research networks in Dementia/Neuroprogressive Conditions; Stroke; and Pain support the delivery of clinical studies across one or more of the above categories.
Details of CSO funding for these 3 research networks is provided in the table below:
Network / Specialty | FY 2020-21 | FY 2021-22 | FY 2022-23 | FY 2023-24 | FY 2024-25 | Total per area |
Neuroprogressive & Dementia | £506,000 | £677,000 | £777,000 | £829,000 | £855,000 | £3,644,000 |
Stroke | £616,000 | £641,000 | £689,000 | £734,000 | £757,000 | £3,437,000 |
NRS Pain | £14,404 | £14,821 | £18,000 | £28,500 | £30,000 | £105,725 |
Total per Financial Year | £1,136,404 | £1,332,821 | £1,484,000 | £1,591,500 | £1,642,000 | £7,186,725 |
- Asked by: Jackie Baillie, MSP for Dumbarton, Scottish Labour
-
Date lodged: Tuesday, 14 January 2025
-
Current Status:
Answered by Jenni Minto on 24 January 2025
To ask the Scottish Government what recommendations it has received from the Director of Screening, NHS National Services Scotland, regarding implementing lung cancer screening as a new targeted screening programme.
Answer
I refer the member to the answer to question S6W-33241 on 24 January 2025. All answers to written parliamentary questions are available on the Parliament’s website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers
- Asked by: Jackie Baillie, MSP for Dumbarton, Scottish Labour
-
Date lodged: Thursday, 16 January 2025
-
Current Status:
Answered by Jenni Minto on 24 January 2025
To ask the Scottish Government for what reason it has proposed reducing the Young Patients Family Fund by £700,000 in its draft Budget 2025-26, and what its response is to reported concerns that this sets a precedent for further reductions to the support that children and young people with cancer, and their families, may need.
Answer
The Young Patients Family Fund (YPFF) is designed to support the families of all babies, children and young people from birth to age 18 who require inpatient care in Scotland, regardless of diagnosis.
The YPFF is a demand-led fund and the Scottish Government has ensured full funding against demand in each year since its launch on 26 July 2021. The 2025-26 budget has been set based on expected demand levels and the Scottish Government remains committed to provide full funding for the YPFF in 2025-26.
Other financial support is available to children and young people with a cancer diagnosis and their families for travel to hospital via the patient travel expenses reimbursement schemes. Under those schemes, patients and authorised escorts can reclaim reasonable costs of travel associated with attending a hospital appointment, in line with eligibility criteria and medical requirements.
- Asked by: Jackie Baillie, MSP for Dumbarton, Scottish Labour
-
Date lodged: Thursday, 09 January 2025
-
Current Status:
Answered by Jenni Minto on 23 January 2025
To ask the Scottish Government whether it will provide multi-annual funding for (a) long COVID and (b) myalgic encephalomyelitis (ME) services in NHS boards.
Answer
The draft budget published on 4 December 2024 includes new investment of £4.5 million to deliver new specialist support across the country for long COVID, ME, Chronic Fatigue, and other similar conditions.
The funding commitment is for 2025-26 only at this stage. As the Cabinet Secretary outlined in his letter to the Health, Social Care and Sport Committee on 4 December 2024, “the Scottish Government operates an annual budget due to the single year settlement from the UK Government”. The UK spending review in the spring will provide much needed clarity on future funding levels which will help to inform our budget setting and move spending onto a more sustainable path. We would recommend that the question of a multi-year commitment is revisited after the UK Government spending review.
- Asked by: Jackie Baillie, MSP for Dumbarton, Scottish Labour
-
Date lodged: Wednesday, 15 January 2025
-
Current Status:
Answered by Neil Gray on 23 January 2025
To ask the Scottish Government what plans it has to renew the Collaborative and Compassionate Care – The Cancer Strategy for Children and Young People in Scotland 2021-2026.
Answer
The delivery of the Cancer Strategy for Children and Young People in Scotland 2021- 2026 continues to be taken forwards by the Managed Service Network for Children and Young People with Cancer (MSN CYPC) into 2026.
The progression of actions in the strategy are regularly reviewed by MSN CYPC and will inform any future national strategy approach required to ensure that children and young people with cancer will have access to the best possible treatment and care.
- Asked by: Jackie Baillie, MSP for Dumbarton, Scottish Labour
-
Date lodged: Wednesday, 15 January 2025
-
Current Status:
Answered by Neil Gray on 23 January 2025
To ask the Scottish Government what financial support it provides to 18- to 25-year-olds to attend day appointments for cancer treatment.
Answer
Health Boards are expected to support patients and their families in identifying and accessing available support. Financial support for travel is available for patients and authorised escorts, according to eligibility criteria and medical requirements, through schemes such as the Patient Travel Expenses Scheme (PTES) and the Highlands and Islands Travel Scheme (HITS).
Scottish Government has funded Young Lives Vs Cancer to provide practical advice and emotional and financial support to young people diagnosed with cancer and their families. This includes advice on potential welfare benefits as well as direct grants.
Further to this, we are working in partnership with Macmillan to improve the service we offer patients with cancer through the Transforming Cancer Care Programme (TCC). This partnership with Macmillan is worth £27 million and is the first of its kind in the UK. The programme ensures that every patient with cancer in Scotland has access to a specialist key support worker, who can provide emotional, financial, and practical support.
- Asked by: Jackie Baillie, MSP for Dumbarton, Scottish Labour
-
Date lodged: Wednesday, 15 January 2025
-
Current Status:
Answered by Neil Gray on 23 January 2025
To ask the Scottish Government whether it will capture the experience of under 16-year-olds with cancer, and their parents, in a survey, similar to the surveys of those over 16 with the condition.
Answer
The Managed Service Network for Children and Young People with Cancer (MSN CYPC) are currently working with Young Lives vs. Cancer (YLvC) to take forward learning from the NHS England and Picker Institute U16 Cancer Patient Experience Survey, to see if this can be developed for children and young people with cancer in Scotland.
Additionally, the MSN CYPC provides a range of patient experience support services such as the Youth Advisory Forum which provides children and young people with cancer with the opportunity to share experiences with each other as well as identifying gaps and improve the quality of services by providing feedback. The Parent, Carer and Families Forum, also facilitated by MSN CYPC, gives a voice to the youngest children with cancer, and their support networks which enables their views to also be captured.
- Asked by: Jackie Baillie, MSP for Dumbarton, Scottish Labour
-
Date lodged: Wednesday, 15 January 2025
-
Current Status:
Answered by Neil Gray on 23 January 2025
To ask the Scottish Government what its response is to reported concerns that funding measures announced in its draft Budget 2025-26 do not go far enough to address the challenges facing children and young people with cancer.
Answer
The dedicated Cancer Strategy for Children and Young People in Scotland 2021- 2026 was published in 2021. This strategy emphasises the Scottish Government’s commitment to improving the distinct care and support services required for children and young people with cancer. Scotland is the only UK-nation to have in place a cancer strategy dedicated to children and young people with cancer.
Our draft Budget 2025-2026 includes a record £21 billion investment in health and social care services, including for services for children and young people with cancer.